Quentin McCubbin - 17 Aug 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)

Role
Chief Manufacturing Officer
Signature
/s/ James P. Abely, Attorney-in-Fact for Quentin McCubbin
Issuer symbol
KRRO
Transactions as of
17 Aug 2022
Net transactions value
$0
Form type
4
Filing time
19 Aug 2022, 16:01:19 UTC
Previous filing
07 Jul 2022
Next filing
27 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Stock Option Award +90,000 90,000 17 Aug 2022 Common Stock 90,000 $2.14 Direct F1, F2
transaction FREQ Stock Option Disposed to Issuer -90,000 -100% 0 17 Aug 2022 Common Stock 90,000 $38.99 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% on January 19, 2022, and in equal monthly installments on the same day of each month thereafter and will be fully vested and exercisable on January 19, 2025.
F2 The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options.